Literature DB >> 24602955

Point prevalence of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae in Maryland.

J Kristie Johnson1, Lucy E Wilson, Licheng Zhao, Katherine Richards, Kerri A Thom, Anthony D Harris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24602955      PMCID： PMC4183360          DOI： 10.1086/675610

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


× No keyword cloud information.
  9 in total

Review 1.  Carbapenemases: the versatile beta-lactamases.

Authors:  Anne Marie Queenan; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

2.  Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustration.

Authors:  David Landman; Elizabeth Babu; Neha Shah; Paul Kelly; Olafisoye Olawole; Martin Bäcker; Simona Bratu; John Quale
Journal:  J Antimicrob Chemother       Date:  2012-02-29       Impact factor: 5.790

Review 3.  Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention.

Authors:  Neil Gupta; Brandi M Limbago; Jean B Patel; Alexander J Kallen
Journal:  Clin Infect Dis       Date:  2011-07-01       Impact factor: 9.079

4.  Detection of the Klebsiella pneumoniae carbapenemase type 2 Carbapenem-hydrolyzing enzyme in clinical isolates of Citrobacter freundii and K. oxytoca carrying a common plasmid.

Authors:  J Kamile Rasheed; James W Biddle; Karen F Anderson; Laraine Washer; Carol Chenoweth; John Perrin; Duane W Newton; Jean B Patel
Journal:  J Clin Microbiol       Date:  2008-04-02       Impact factor: 5.948

5.  Carbapenem-resistant enterobacteriaceae: a statewide survey of detection in Massachusetts hospitals.

Authors:  Evangeline Thibodeau; Robert Duncan; David R Snydman; Barbara Bolstorff; Johanna Vostok; Kerri Barton; Alfred Demaria
Journal:  Infect Control Hosp Epidemiol       Date:  2012-07-24       Impact factor: 3.254

6.  Assessing the burden of Acinetobacter baumannii in Maryland: a statewide cross-sectional period prevalence survey.

Authors:  Kerri A Thom; Lisa L Maragakis; Katie Richards; J Kristie Johnson; Brenda Roup; Patricia Lawson; Anthony D Harris; Elizabeth P Fuss; Margaret A Pass; David Blythe; Eli N Perencevich; Lucy Wilson
Journal:  Infect Control Hosp Epidemiol       Date:  2012-07-23       Impact factor: 3.254

7.  Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies.

Authors:  Gopi Patel; Shirish Huprikar; Stephanie H Factor; Stephen G Jenkins; David P Calfee
Journal:  Infect Control Hosp Epidemiol       Date:  2008-12       Impact factor: 3.254

8.  Use of active surveillance cultures to detect asymptomatic colonization with carbapenem-resistant Klebsiella pneumoniae in intensive care unit patients.

Authors:  David Calfee; Stephen G Jenkins
Journal:  Infect Control Hosp Epidemiol       Date:  2008-10       Impact factor: 3.254

9.  Vital signs: carbapenem-resistant Enterobacteriaceae.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-03-08       Impact factor: 17.586
  9 in total
  3 in total

Review 1.  The role of surveillance systems in confronting the global crisis of antibiotic-resistant bacteria.

Authors:  Federico Perez; Maria Virginia Villegas
Journal:  Curr Opin Infect Dis       Date:  2015-08       Impact factor: 4.915

Review 2.  Carbapenem-Resistant Enterobacterales in Long-Term Care Facilities: A Global and Narrative Review.

Authors:  Hsin-Yu Chen; Shio-Shin Jean; Yu-Lin Lee; Min-Chi Lu; Wen-Chien Ko; Po-Yu Liu; Po-Ren Hsueh
Journal:  Front Cell Infect Microbiol       Date:  2021-04-23       Impact factor: 5.293

3.  A risk score based on pediatric sequential organ failure assessment predicts 90-day mortality in children with Klebsiella pneumoniae bloodstream infection.

Authors:  Shuang Li; Jingxian Liu; Feng Chen; Kang Cai; Jintong Tan; Wei Xie; Rong Qian; Xiaoqin Liu; Wenhong Zhang; Huimin Du; Ying Liu; Lisu Huang
Journal:  BMC Infect Dis       Date:  2020-12-02       Impact factor: 3.090
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.